Physicochemical Properties
Molecular Formula | C27H30O6 |
Molecular Weight | 450.52 |
Exact Mass | 450.204 |
CAS # | 65893-94-9 |
PubChem CID | 44257338 |
Appearance | White to off-white solid powder |
LogP | 6.167 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 9 |
Heavy Atom Count | 33 |
Complexity | 746 |
Defined Atom Stereocenter Count | 0 |
InChi Key | RHXDATRKLOYVTC-UHFFFAOYSA-N |
InChi Code | InChI=1S/C27H30O6/c1-17(2)9-11-31-22-8-7-19(13-23(22)32-12-10-18(3)4)21-16-33-25-15-20(29-5)14-24(30-6)26(25)27(21)28/h7-10,13-16H,11-12H2,1-6H3 |
Chemical Name | 3-[3,4-bis(3-methylbut-2-enoxy)phenyl]-5,7-dimethoxychromen-4-one |
HS Tariff Code | 2934.99.9001 |
Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
Targets | Gli1-DNA Interaction[1] |
ln Vitro | Glabrescione B (5 μM; 24-72 hours) suppresses the proliferation of Gli-dependent basal cell carcinoma[2]. Glabrescione B (1-10 μM; 24-48 hours) reduces Gli1 mRNA expression levels[2]. |
Cell Assay |
Cell Proliferation Assay [1] Cell Types: ASZ001 BCC cells Tested Concentrations: 5 μM Incubation Duration: 24-72 hrs (hours) Experimental Results: Basal cell carcinoma cell proliferation was impaired. Western Blot Analysis[1] Cell Types: ASZ001 BCC cells Tested Concentrations: 1-10 μM Incubation Duration: 24-48 hrs (hours) Experimental Results: Gli1 mRNA expression levels was decreased. |
Animal Protocol |
Animal/Disease Models: Female NOD/SCID (severe combined immunodeficient) mouse (ASZ001 BCC allografts)[2] Doses: 100 μmol/kg Route of Administration: Ip; every second day for 18 days Experimental Results: A significant reduction of tumor growth as well as Gli1 mRNA levels was observed. |
References |
[1]. Polymeric glabrescione B nanocapsules for passive targeting of Hedgehog-dependent tumor therapy in vitro. Nanomedicine (Lond). 2017;12(7):711-728. [2]. Gli1/DNA interaction is a druggable target for Hedgehog-dependent tumors. EMBO J. 2015;34(2):200-217. |
Additional Infomation | Glabrescione B is a methoxyisoflavone. |
Solubility Data
Solubility (In Vitro) | DMSO: 100 mg/mL (221.97 mM) |
Solubility (In Vivo) |
Solubility in Formulation 1: 2.5 mg/mL (5.55 mM) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), suspension solution; with sonication. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: 2.5 mg/mL (5.55 mM) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), suspension solution; with ultrasonication. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.5 mg/mL (5.55 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 2.2197 mL | 11.0983 mL | 22.1966 mL | |
5 mM | 0.4439 mL | 2.2197 mL | 4.4393 mL | |
10 mM | 0.2220 mL | 1.1098 mL | 2.2197 mL |